Orphan Nuclear Receptors as Targets for Drug Development

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.27, Iss.8, 2010-08, pp. : 1439-1468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nuclear Receptors as Drug Targets: New Developments in Coregulators, Orphan Receptors and Major Therapeutic Areas

By Sladek Frances M

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 679-684

Informa Healthcare

Access to resources Recommend Favorite

Nuclear membrane receptors and channels as targets for drug development in cardiovascular diseases

By Bkaily Ghassan Avedanian Levon Jacques Danielle

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 2, 2009-02 ,pp. : 108-119

NRC Research Press

Access to resources Recommend Favorite

Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising Enzymes

By Wang H. LeCluyse E.L.

Clinical Pharmacokinetics, Vol. 42, Iss. 15, 2003-01 ,pp. : 1331-1357

Adis International

Access to resources Recommend Favorite

Editorial [ Nuclear Receptors as Drug Discovery Targets Executive Editor: Sunil Nagpal ]

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 8, 2005-08 ,pp. : 699-700

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Orphan Nuclear Receptors-Coregulator Interactions Controlling Anti-Cancer Drug Metabolism

Current Drug Metabolism, Vol. 9, Iss. 7, 2008-09 ,pp. : 611-613

Bentham Science Publishers

Access to resources Recommend Favorite